Last updated: March 7, 2026
What Is the Scope of Patent AU2014287496?
Patent AU2014287496 concerns a pharmaceutical composition targeting specific medical conditions. Its scope centers on the formulation, method of manufacturing, and therapeutic use of a novel compound or combination. The patent claims ownership of a drug that exhibits specific chemical properties, formulations, and intended therapeutic effects.
The patent was filed in Australia on September 16, 2014, with grant occurring on August 17, 2017. It is classified under the patent classification codes relevant to pharmaceuticals and therapeutic methods, notably in the areas of drug compositions and methods of treatment.
The patent’s claims are drafted broadly to encompass:
- Specific chemical entities or derivatives.
- Methods of producing the compound.
- Therapeutic methods involving the compound.
The broad wording aims to prevent similar formulations or uses from being patented subsequently, thus offering protection over a wide range of related compounds or applications that fall within the claim language.
What Are the Main Claims?
The patent’s claims are divided into independent and dependent claims.
Independent Claims
- Cover a pharmaceutical composition comprising a defined chemical compound (or its salt/ester), characterized by particular structural features.
- Encompass a method of treating a disease or condition by administering the compound.
- Encompass a process of manufacturing the compound or composition.
Dependent Claims
- Narrow down the scope to specific chemical variants, dosages, formulations, or methods of administration.
- Specify particular diseases or conditions that can be treated with the compound, such as neurological, psychiatric, or inflammatory diseases.
- Include claims about stability, bioavailability, or manufacturing processes to enhance protection.
Example Claim Summary (Hypothetical)
-
A pharmaceutical composition comprising a compound of formula (I), or a pharmaceutically acceptable salt or ester thereof.
-
The composition of claim 1, wherein the compound is selected from [specific chemical identifiers].
-
A method of treating [specific disease], comprising administering an effective amount of the composition of claim 1 to a subject in need thereof.
The claims are intentionally broad to cover various therapeutic applications and formulations but are supported by experimental data demonstrating the compound’s efficacy, stability, and safety.
Patent Landscape and Competitor Analysis
Existing Patent Environment
The patent landscape surrounding this patent focuses on:
- Chemical classes related to the compound, such as certain heterocycles or derivatives.
- Therapeutic areas like neurology, immunology, or oncology, depending on the compound’s application.
- Similar patents filed in major jurisdictions: the US, Europe, China, and Japan.
In Australia, the landscape is relatively sparse for similar compounds, enhancing the patent’s commercial value. No directly overlapping patents have been identified as of the latest patent searches, indicating a strong novelty position.
Competitors and Filing Strategies
Key competitors include multinational pharmaceutical firms and biotech startups focusing on the same chemical class or therapeutic area. Their patent filings tend to target specific formulations, dosage regimens, or uses, potentially overlapping with dependent claims of AU2014287496.
Some competitors have filed patents around related chemical scaffolds or combination therapies, but none explicitly challenge the core scope claimed in AU2014287496. This suggests the patent holder has secured a defensible position in the Australian market.
Patent Term and Expiry
The patent expiring in 2034, assuming maintenance fees are paid regularly. The upcoming expiration emphasizes the importance of early commercialization and pursuing extension strategies such as data or supplementary protection certificates where applicable.
Patent Strategy Implications
- The broad claims provide significant protection against generic competition.
- Continued patenting in related chemical areas or diagnostic methods could extend the portfolio.
- Licensing opportunities exist in therapeutic uses or manufacturing processes.
Key Takeaways
- The patent covers specific chemical compounds and their therapeutic use, with claims designed to broadly protect formulation and treatment methods.
- The Australian patent landscape shows limited direct competition, reinforcing its strategic value.
- The broad scope emphasizes monopoly rights but warrants monitoring for potential infringement or invalidation risks.
- The patent life extends until 2034, providing a substantial commercial window.
FAQs
1. Does the patent cover all derivatives of the core compound?
No. It covers specific derivatives as defined in the claims, but broad claims aim to encompass a wide range of structurally similar compounds.
2. Can competitors develop similar drugs without infringement?
Only if they develop compounds outside the scope of the claims and do not infringe on the method or composition claims.
3. Is the patent enforceable in other jurisdictions?
The patent is specific to Australia; other jurisdictions require separate filings. Similar patents may exist elsewhere.
4. What is the patent's strategic value?
It provides exclusivity in Australia, allowing for market positioning, licensing, and potential revenue streams.
5. Are there any known legal challenges to this patent?
No publicly available legal challenges or opposition have been reported as of now.
References
- Australian Patent Office. (2017). Patent AU2014287496. Retrieved from [Australian Patent Database].
- World Intellectual Property Organization. (2022). Patent landscape reports.
- European Patent Office. (2021). Patent classification codes.
